Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
---|
12/03/2003 | EP1367123A1 Neurotonin and use thereof |
12/03/2003 | EP1366173A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
12/03/2003 | EP1366162A2 Putative proteins and nucleic acids encoding same |
12/03/2003 | EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
12/03/2003 | EP1366079A2 Nuclear hormone receptor ligand binding domain |
12/03/2003 | EP1365645A2 Transgenic mice containing targeted gene disruptions |
12/03/2003 | EP1365643A2 Microinjection assembly and methods for microinjecting and reimplanting avian eggs |
12/03/2003 | CN1459457A Method of producing human forcing erythrogenin using transgene animal mammary gland |
12/03/2003 | CN1129355C Technology for mass rearing grained moth |
12/02/2003 | US6657105 Monitoring animal for cardiovascular disorders; insert viral gene into animal, monitor animal for cardiovascular disorders |
12/02/2003 | US6657104 Cell-based, and whole-animal-based assays for detecting substances having therapeutic activity toward cardiac hypertrophy. |
12/02/2003 | US6656717 Cyclic AMP phosphodiesterase isoforms and methods of use |
12/02/2003 | US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides |
12/02/2003 | US6656705 Sciellin and uses thereof |
12/02/2003 | US6656704 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
12/02/2003 | US6656475 Modulating growth of muscle or adipose tissue in eukaryotic organism using agent that affects myostatin signal transduction |
11/27/2003 | WO2003097876A1 Method for improving efficiencies in livestock production |
11/27/2003 | WO2003097871A2 Marker molecules associated with lung tumors |
11/27/2003 | WO2003097826A1 Use of minos in functional genomics |
11/27/2003 | WO2003097818A1 A method for producing transgenic animal mammary glands secreting human erythropoietin (epo). |
11/27/2003 | WO2003097812A2 Transgenic ungulates capable of human antibody production |
11/27/2003 | WO2003097682A1 Methods for identifying and developing compounds that interact with voltage-gated potassium channels of the kv4 family |
11/27/2003 | WO2003096804A1 Heparin-binding epidermal growth factor-like growth factor gene-modified animal, screening method, embryonic stem cells and preventive and/or remediy for heart failure |
11/27/2003 | WO2003096799A2 Multiple closed nucleus breeding for swine production |
11/27/2003 | WO2003083096A3 Cancer associated protein kinases and their uses |
11/27/2003 | WO2003078613A3 Serine hydroxymethyltransferase as a target for herbicides |
11/27/2003 | WO2003062270A3 Fluorescent protein from aequorea coerulscens and uses therof |
11/27/2003 | WO2003050252A3 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use |
11/27/2003 | WO2003037932A3 Human coagulation factor vii polypeptides |
11/27/2003 | WO2003029464A3 Genes associated with mast cell activation |
11/27/2003 | WO2003027147A3 Human coagulation factor vii polypeptides |
11/27/2003 | WO2003024482B1 Crustaceans as production systems for therapeutic proteins |
11/27/2003 | WO2003022868A3 Metal binding proteins and associated methods |
11/27/2003 | WO2003012064A3 Nucleic acids and encoded polypeptides associated with bipolar disorder |
11/27/2003 | WO2002103472A9 Pet food kiosk |
11/27/2003 | WO2002086113A3 Enzyme and snp marker for disease |
11/27/2003 | WO2002068459A3 Non aggregating fluorescent proteins and methods for using the same |
11/27/2003 | US20030221209 Modified proteinase inhibitors |
11/27/2003 | US20030221207 Cardiac-specific 11beta hydroxysteroid dehydrogenase type 2 transgenic mice |
11/27/2003 | US20030221206 Using in vitro fertilization to produce gentically engineered animals for use as models for prevention and treatment of disease |
11/27/2003 | US20030221205 Olfactory and pheromones G-protein coupled receptors |
11/27/2003 | US20030221199 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema |
11/27/2003 | US20030220276 HIV vaccine and method of use |
11/27/2003 | US20030219866 Culturing pluripotent cells and monitoring expression of transcriptional marker protein (OCT4); animal models for cell differentiation; veterinary medicine |
11/27/2003 | US20030219821 Methods for identifying oncogenes and tumor-associated proteins |
11/27/2003 | US20030219819 Method for improving efficiencies in livestock production |
11/27/2003 | US20030219739 Comprises muscle protein for treating and preventing of muscle atrophy |
11/27/2003 | US20030219442 Human monoclonal antibodies to influenza M2 protein and methods of making and using same |
11/27/2003 | US20030219385 Contrast agents for magnetic resonance imaging and methods related thereto |
11/27/2003 | CA2486583A1 Marker molecules associated with lung tumors |
11/27/2003 | CA2484655A1 Transgenic ungulates capable of human antibody production |
11/27/2003 | CA2484642A1 Multiple closed nucleus breeding for swine production |
11/26/2003 | EP1365032A1 Marker molecules associated with lung tumors |
11/26/2003 | EP1364578A1 Schizophrenia-like mental disease model animal, method of constructing the same and use thereof |
11/26/2003 | EP1364056A2 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits |
11/26/2003 | EP1364019A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
11/26/2003 | EP1364004A2 Administration of nucleic acid sequence to female animal |
11/26/2003 | EP1363994A2 Thymic epithelial progenitor cells and uses thereof |
11/26/2003 | EP1363946A2 Methods of dissociating nongenotropic from genotropic activity of steroid receptors |
11/26/2003 | EP1363936A1 Juvenile hormone esterase |
11/26/2003 | EP1363528A2 Methods for diagnosing and treating heart disease |
11/26/2003 | CN1457634A Mouse model of hipatitis B virus gene positioning integration to result in liver cell callcer |
11/25/2003 | US6654627 Method and device for recording polarized electromagnetic radiation of inactivated strain of pathogenic microorganisms onto a crystal, method and device for changing activity of strain of pathogenic microorganisms, method for eliminating strain of pathogenic microorganisms from human or animal organism |
11/25/2003 | US6653382 Ethylene-unsaturated carboxylic acid copolymer; ionomers; resilience, melt processability |
11/25/2003 | US6653116 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
11/25/2003 | US6652854 Administering agents that hinder CD30/CD30L (CD30L=ligand of CD30) binding; animal model of arthritis for drug screening |
11/21/2003 | CA2424937A1 Methods for improving efficiencies in livestock production |
11/21/2003 | CA2387003A1 Method for improving efficiencies in livestock production |
11/20/2003 | WO2003095971A2 Posh nucleic acids, polypeptides and related methods |
11/20/2003 | WO2003095667A2 Autoimmune conditions and nadph oxidase defects |
11/20/2003 | WO2003095643A1 Method of inhibiting gene expression |
11/20/2003 | WO2003095640A2 Transgenic rat as animal model for human huntingdon's disease |
11/20/2003 | WO2003065971A9 Non-myeloablative tolerogenic treatment with tyrphostins |
11/20/2003 | WO2003055915A3 Human netrin receptor and uses thereof |
11/20/2003 | WO2003054012A3 Leptin proteins |
11/20/2003 | WO2003042401A3 Novel chromophores/fluorophores and methods for using the same |
11/20/2003 | WO2003029912A3 Animal healthcare, well-being and nutrition |
11/20/2003 | WO2003012062A3 Animal model with disrupted fgf14 gene |
11/20/2003 | WO2002085287A3 Minimal adenoviral vectors for immunization |
11/20/2003 | WO2002083736A3 G-protein coupled receptor molecules and uses thereof |
11/20/2003 | WO2002062395A3 A method and system for introducing a gene into a human stem cell |
11/20/2003 | WO2002022886A3 Expression of genes in diabetes mellitus and insulin resistance |
11/20/2003 | US20030217379 Defective tyrosine phosphatase animal model for diagnosing and treating diabetes and eating disorders |
11/20/2003 | US20030217378 Preparing transgenic animal via nuclear transfer; animal models |
11/20/2003 | US20030217374 Genetically engineered rodent for use in generating immunoglobulins; genetic vaccines; antitumor agents; gene therapy |
11/20/2003 | US20030217373 Transgenic animals bearing human Ig-lambda light chain genes |
11/20/2003 | US20030217371 Therapeutic methods employing PAI-1 inhibitors and transgenic non-human animal for screening candidate PAI-1 inhibitors |
11/20/2003 | US20030217370 Transgenic animal expressing alpha-synuclein and uses thereof |
11/20/2003 | US20030215898 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
11/20/2003 | US20030215861 Methods of treating a BRCA associated disorder |
11/20/2003 | US20030215852 Novel pancortin-Pablo protein interactions and methods of use thereof |
11/20/2003 | US20030215823 Uses of galanin GALR2 receptors |
11/20/2003 | US20030215423 Drug delivery a genetic engineered vector, encoding protein hormone in vivo; a helper dependent adenoviral vector |
11/20/2003 | CA2523888A1 Transgenic rat and the use thereof in the animal model for human huntingdon's disease and nuclear constructs, vectors and cells for the production thereof |
11/19/2003 | EP1362911A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
11/19/2003 | EP1362510A2 A mouse model for hepatocellular carcinoma by targeted integration of hepatitis B virus genes |
11/19/2003 | EP1362102A1 Pg-3 and biallelic markers thereof |
11/19/2003 | EP1362093A1 Rapid production of monoclonal antibodies |
11/19/2003 | EP1361789A2 Method for embryo transfer after impregnation of the recipient female |
11/19/2003 | EP1361788A2 Primordial germ cell-based germ line production of birds |